Role of sweet taste receptors in the activation of NLRP3 inflammasome signaling in diabetic kidney disease
10.3760/cma.j.issn.1000-6699.2018.07.011
- VernacularTitle: 甜味受体在糖尿病肾病NLRP3炎症信号活化中的作用
- Author:
Luping ZHOU
1
;
Wei HUANG
;
Yong XU
;
Youhua XU
;
Yang LONG
;
Chenlin GAO
Author Information
1. Department of Endocrinology, Affiliated Hospital of Southwest Medical University, Luzhou 646000, China
- Publication Type:Journal Article
- Keywords:
Sweet taste receptors;
Reactive oxygen species;
NLRP3 inflammasome;
Diabetic kidney disease
- From:
Chinese Journal of Endocrinology and Metabolism
2018;34(7):587-593
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the role of sweet taste receptors(STRs)in the activation of reactive oxygen species (ROS)-NLRP3 inflammasome signaling in diabetic kidney disease(DKD).
Methods:DKD mouse were established by high-fat diet and streptozotocin. After mouse glomerular mesangial cells(GMCs)were exposed to high glucose, STRs(T1R2/T1R3)and associated signaling components and NLRP3 inflammasome signaling components expressions were detected. After GMCs were treated with STRs inhibitor lactisole, the production of ROS was detected and the role of STRs in the activation of NLRP3 signaling was investigated.
Results:Under high glucose condition, the expressions of T1R2, T1R3, Gα-gustducin, phospholipase C-β2, and TRPM5 were significantly decreased in vivo and in vitro(all P<0.05)and ROS-NLRP3 signaling was activated(all P<0.05). Lactisole significantly mitigated the production of ROS and the activation of NLRP3 inflammasome signaling stimulated by high glucose in GMCs(all P<0.05).
Conclusion:The STRs(T1R2/T1R3)-mediated signaling pathway may be involved in the regulation of ROS-NLRP3 inflammatory signaling, suggesting that STRs may act as new therapeutic targets of DKD. (Chin J Endocrinol Metab, 2018, 34: 587-593)
